Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Canopy Growth

Aurora Cannabis

Cannabis stocks are sinking today after Canopy Growth's Q4 revenue came in below analysts' average outlook. The post Cannabis Stocks ACB, CGC, TLRY Fall as Earnings Disappoint appeared first on InvestorPlace.

Cannabis Stocks ACB, CGC, TLRY Fall as Earnings Disappoint

SNDL Inc.

Selling pot is apparently quite difficult to do profitably.

3 Hot Marijuana Stocks That Could Easily Turn $5,000 Into $500

HEXO Corp

No prizes for guessing which country just reported a big leap in weed sales.

Why Canadian Marijuana Stocks Soared Today

Tilray Brands Inc (NASDAQ: TLRY) shares are trading higher Thursday after the company announced the launch of its CBD lifestyle brand POLLEN on the Amazon.com Inc (NASDAQ: AMZN) UK platform. Pollen is designed to help uncomplicate wellness routines and elevate the CBD experience for.

Cannabis On Amazon? Why Tilray Stock Is Trading Higher

Cronos Group

3 Canadian Marijuana Stocks To Watch At The End Of The Month The post Top Canadian Marijuana Stocks To Watch This June appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Watch This June

TLRY stock has seen more volatility than some of the other cannabis plays in recent weeks, but it's also been trading at a discount. The post Here Are 2 Reasons to Keep You Interested in Tilray appeared first on InvestorPlace.

Here Are 2 Reasons to Keep You Interested in Tilray

Innovative, Delicious CBD Designed to Make You Feel Your Kind of Good Innovative, Delicious CBD Designed to Make You Feel Your Kind of Good

Tilray Launches CBD Lifestyle Brand, Pollen, on Amazon UK

Tilray aims to reach US$4BN in revenue by the end of 2024, with an opportunity of US$1BN in Europe. Compared to other companies in the sector, Tilray has reasonably sound gross revenues and is working on becoming free cash flow positive.

Tilray Brands: Almost Good Enough

Marijuana Stocks To Watch While The Sector Is Down The post Are Canadian Marijuana Stocks A Buy Right Now? 3 For Your List In May appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Canadian Marijuana Stocks A Buy Right Now? 3 For Your List In May

Curaleaf Holdings, Inc.

Tilray is one of the better-known cannabis stocks, even though it is a Canadian operator. Curaleaf is one of the biggest operators in the United States and globally with a coast-to-coast footprint.

Tilray Vs. Curaleaf: Which Cannabis Stock Is The Better Buy?

Camber Energy

FuboTV

Mullen Automotive

Paysafe

Penny stocks to buy according to options traders today. The post Best Penny Stocks To Buy?

Best Penny Stocks To Buy? 5 With Massive Bullish Options Volume Today

Agrify

Emerald Expositions Events

GrowGeneration Corp

High Tide

Akerna Corp

WM Technology

Chicago Atlantic Real Estate Finance

Urban-gro

Village Farms International

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

12 Cannabis Stocks in the Red and Still Making Headlines

Is Tilray the best cannabis stock to hold if marijuana legalization happens in the U.S.?

Down 80% From Its High, Can Tilray Stock Spark Again?

Don't be enticed by Tilray's ambitious revenue projection as multiple negative factors are likely to weigh on TLRY stock. The post Tilray Stock Is a No-Go As Stifel Stifles Cannabis-Market Outlook appeared first on InvestorPlace.

Tilray Stock Is a No-Go As Stifel Stifles Cannabis-Market Outlook

Nearly 77 million shares short at end of April. 2024 revenue target aggressive without legislation.

Tilray Short Interest Hits New High

Advanced Micro Devices

Petroleo Brasileiro

Uber

New Jersey's state pension materially increased investments in chip maker AMD, marijuana producer Tilray, ride-hailing firm Uber, and energy giant Petrobras.

Giant Pension Bought AMD, Tilray, Uber, and Petrobras Stock

Blink Charging

Coinbase

Kinross Gold

Lithium Americas Corp

UiPath

XPeng

These growth stocks have corrected sharply so far in 2022 and now seem overvalued, making them appealing for fresh exposure. The post 7 Growth Stocks That Have Become Deep Value Plays appeared first on InvestorPlace.

7 Growth Stocks That Have Become Deep Value Plays

3 Canadian Marijuana Stocks To Watch This Upcoming Week The post 3 Canadian Marijuana Stocks To Watch Next Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Canadian Marijuana Stocks To Watch Next Week

Shares of several companies in the broader cannabis and consumer discretionary sector, including Tilray Inc (NASDAQ: TLRY), are trading lower amid overall weakness as traders continue to digest Wednesday's Fed rate hike announcement. The Federal Reserve raised its target fed funds rate by 0.5%.

What's Going On With Tilray Shares Falling Near 52-Week Lows Today?

Stifel analyst W. Andrew Carter on Monday said the firm continues to approach the cannabis sector with “negative overall bias” amid a reduced outlook for the U.S. market and lackluster performance in the hydroponics sector.

Cannabis Watch: Stifel cuts cannabis industry view as analysts weigh Tilray

Tilray Brands keeps burning through cash and a recession won't help things. TLRY stock is could keep dropping unless it can stop burning through cash, or if the economic recession gets worse.

Tilray Brands Keeps Burning Through Cash and a Recession Won't Help Things

AbbVie

AFC Gamma

Green Thumb Industries Inc.

Robinhood

Innovative Industrial Properties

Jazz Pharmaceuticals

Leafly Holdings

Scotts Miracle-Gro

Trulieve Cannabis Corp.

The Cannabis Industry And Parts Of The Sector To Watch In 2022 The post The Best Marijuana Stocks In 2022 And The Different Cannabis Sectors To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

The Best Marijuana Stocks In 2022 And The Different Cannabis Sectors To Watch Right Now

TLRY stock can be expected to continue falling while it awaits federal-level legalization and access to the American market. The post Tilray Will Struggle Until the U.S. Legalizes Cannabis appeared first on InvestorPlace.

Tilray Will Struggle Until the U.S. Legalizes Cannabis

These top cannabis stocks are worth buying after a deep correction, as they can rally on hopes of more states legalizing marijuana. The post 3 Top Cannabis Stocks to Buy as State Legalization Grows appeared first on InvestorPlace.

3 Top Cannabis Stocks to Buy as State Legalization Grows

A Congress nervous about upcoming midterms could pave the way for marijuana legalization. TLRY stock tends to perform well during such news.

Investors Should Buy Tilray Stock as Legalization Approaches

News for Tilray Brands Stock (TLRY)